A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
Open Access
- 2 April 2020
- journal article
- letter
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 91 (6), 673-674
- https://doi.org/10.1136/jnnp-2019-322210
Abstract
No abstract availableFunding Information
- Patrick Berthoud Charitable Trust
- Parkinson's UK
- Medical Research Council
- Cure Parkinson's Trust
- National Institute for Health Research
- Wellcome Trust
This publication has 10 references indexed in Scilit:
- Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementiaBrain, 2019
- Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy BodiesMolecular Neurobiology, 2019
- Survival and dementia in GBA‐associated Parkinson's disease: The mutation mattersAnnals of Neurology, 2016
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson'sAnnals of Neurology, 2016
- The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohortJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohortBrain, 2013
- Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activityMolecular Genetics and Metabolism, 2012
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disordersActa Neuropathologica, 2010
- Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's diseaseAnnals of Neurology, 2007